शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
SANOFICONRNSESanofi Consumer Healthcare India Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 27 May, 2025 · 11:16 IST

Citigroup Global Markets India Private Limited has Submitted to the Exchange a copy of post offer advertisement under Regulation 18(12) of�the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 for the attention of the shareholders of the Company.

Open offer triggeredListed-company acquisitionStrategic Transactions View source PDFExplain this filing

SANOFICONR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.0%Reaction day
₹5049.89
prior close
₹5001.00
announcement price
In-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)-0.1%+1.0% vs market
Pharmaceuticals peers, median of 147sector+0.1%+0.8% vs sector

On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 0.8 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.0
10m
-0.0
15m
-0.0
30m
-0.4
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.0-0.1+1.0+0.1+0.8
Next day
+0.0+0.2-0.2-0.0+0.0
2d
-0.6+0.6-1.2+0.8-1.4
3d
+4.0+0.9+3.1+0.3+3.7
4d
+8.8+1.0+7.8+0.0+8.8
5d
+5.3+0.7+4.6-0.7+6.0
1w
+0.7+1.8-1.1-0.1+0.7
15d
-0.0+1.7-1.7-0.9+0.9
1m
-0.6+3.1-3.7-0.8+0.2
2m
-1.5+1.7-3.2+0.6-2.1
3m
+0.9-1.0+1.9-3.0+3.9
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 147Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Citigroup Global Markets India Private Limited, acting as the manager to an offer, has submitted a post offer advertisement to the exchange under Regulation 18(12) of the SEBI Substantial Acquisition of Shares and Takeovers Regulations, 2011. This filing is made for the attention of the shareholders of Sanofi Consumer Healthcare India Limited and relates to the conclusion of an open offer made to acquire shares from public shareholders. A post offer advertisement is published after the open offer window closes and typically discloses the final acceptance levels and the acquirer's intention regarding the next steps, such as maintaining listing or proceeding with delisting.

Likely market impact

Shareholders who tendered their shares in the open offer will get clarity on the final acceptance ratio and settlement timeline. For remaining public shareholders, this signals that the acquirer has completed the tendering phase and may be evaluating whether to proceed with delisting or maintain the company's listed status, which could affect liquidity and future price discovery.